Edap Tms (NASDAQ:EDAP) Downgraded to Sell at StockNews.com

StockNews.com downgraded shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a research report sent to investors on Friday morning.

Separately, HC Wainwright increased their target price on Edap Tms from $16.00 to $19.00 and gave the company a buy rating in a research note on Monday, April 1st.

Edap Tms Stock Down 2.7 %

NASDAQ:EDAP traded down $0.20 during trading hours on Friday, hitting $7.14. The stock had a trading volume of 30,482 shares, compared to its average volume of 35,174. The company has a current ratio of 2.84, a quick ratio of 2.30 and a debt-to-equity ratio of 0.04. Edap Tms has a 1-year low of $3.60 and a 1-year high of $12.23. The business has a 50 day simple moving average of $7.34 and a two-hundred day simple moving average of $6.30. The company has a market cap of $264.89 million, a PE ratio of -11.33 and a beta of 0.65.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings data on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.13). Edap Tms had a negative net margin of 35.03% and a negative return on equity of 34.33%. The firm had revenue of $21.27 million during the quarter, compared to analyst estimates of $21.30 million. Analysts predict that Edap Tms will post -0.36 EPS for the current year.

Hedge Funds Weigh In On Edap Tms

Large investors have recently added to or reduced their stakes in the company. Milestone Investment Advisors LLC bought a new stake in Edap Tms in the third quarter valued at $39,000. Summit Trail Advisors LLC acquired a new position in shares of Edap Tms during the third quarter valued at $77,000. Miracle Mile Advisors LLC acquired a new position in shares of Edap Tms during the first quarter valued at $136,000. Finally, Rock Springs Capital Management LP increased its holdings in shares of Edap Tms by 14.6% during the third quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock valued at $9,547,000 after purchasing an additional 173,700 shares during the period. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.